Daiichi Sankyo participates in establishment of Global Health Innovative Technology Fund
8 April 2013 | By Daiichi Sankyo
GHIT Fund aims to promote the R&D of new medicines, vaccines & diagnostics in Japan...
List view / Grid view
News
Lundbeck presents new data on Selincro
8 April 2013 | By H. Lundbeck A/S
New data on Selincro from three phase III studies that show a significant reduction in alcohol consumption in alcohol dependent patients with high risk drinking level...
Teva names Ichiro Kikushige as CEO of Teva Seiyaku, Japan
8 April 2013 | By Teva Pharmaceutical Industries Ltd
TEVA announced the appointment of Ichiro Kikushige...
Bristol-Myers Squibb announces appointment of Francis Cuss as Executive Vice President and CSO, effective July 1; Elliott Sigal plans to retire
7 April 2013 | By Bristol-Myers Squibb Company
The appointment of Francis Cuss announced...
AstraZeneca announces top-line results from OSKIRA-1 Phase III study of fostamatinib in rheumatoid arthritis
5 April 2013 | By AstraZeneca
AstraZeneca announced top-line results of OSKIRA-1...
Azbil BioVigilant (ABV) announces partnership with University of Tennessee (UT) Pharmacy College
4 April 2013 | By Azbil BioVigilant
UT to implement ABV’s rapid microbial monitoring in new aseptic processing area...
Roche launches new test for diagnosis and monitoring of thyroid cancer
4 April 2013 | By Roche
The Elecsys Calcitonin marker expands Roche’s portfolio for improved thyroid management
The Lancet publishes SELECT study evaluating efficacy and safety of daclizumab HYP in multiple sclerosis
4 April 2013 | By Biogen Idec
Results from the DAC HYP SELECT clinical trial...
GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab) in patients with vasculitis
3 April 2013 | By GlaxoSmithKline
GSK announced the start of a Phase III study...
Synthon chooses Avacta’s Optim 1000 for high throughput formulation studies
3 April 2013 | By kdm communications limited
Pharmaceutical developers at Synthon have chosen an Optim 1000 high throughput, micro-volume protein analysis system...
Sun shines on Indian generics manufacturers
3 April 2013 | By GlobalData
India is becoming a key market for generic medicines...
Next-generation circulating tumor cell test demonstrates high efficiency and accuracy in new study
3 April 2013 | By Johnson & Johnson
“CELLSEARCH® the first and only FDA-cleared CTC test..."
CHOP collaborates with Pfizer’s Centers for Therapeutic Innovation to speed pediatric research & development
3 April 2013 | By Pfizer
CHOP and Pfizer are joining forces...
GW Pharmaceuticals announces new US patent allowance for delivery of its SATIVEX® formulation
3 April 2013 | By FTI Consulting
GW has obtained a patent in the US...
GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK
3 April 2013 | By GlaxoSmithKline
Marketing authorisation for quadrivalent (four-strain) influenza vaccine...
